Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
with the University, in accordance with the Immigration, Asylum and Nationality Act 2006. Full-Time, Permanent Applications are invited for the post of SF Research Contracts Manager in the Research and
-
recruitment audience. You’ll also develop and deliver a reputation marketing strategy that aligns with the University strategy, RH2030s, and wider Marketing & Communications plan, engages audiences and helps us
-
work on ICED’s flagship programmes across Africa and Asia, supporting research on what works to improve the lives of people with disabilities, through employment, education and health programming
-
pay benefit, free on-site gym and wellbeing centre a comprehensive learning and development programme and support for your CPD Prospective applicants are encouraged in the first instance to contact
-
to improve people's health in developing countries by striving for excellence in research, healthcare, and training. Our research program spans basic scientific research, clinical studies, epidemiological
-
About the Role Applications are invited for a Data Scientist based at the Centre for Clinical Pharmacology and Precision Medicine at the William Harvey Research Institute in Charterhouse Square. The
-
the University, in accordance with the Immigration, Asylum and Nationality Act 2006. Full-Time, Fixed-Term Applications are invited for the post of Senior Employer Engagement Officer (Maternity Cover) in
-
for medicine use before and during pregnancy. This postholder would work primarily on a recently funded programme of work to develop a novel approach to understanding and communicating the Safety of Medicines in
-
collaborations with external industry meet our ambitious goals for EDI across the sector. They will contribute to a range of Access Programme activities at the National Lab and Challenge Projects in the CDT
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing